Connection

Jesse Bloom to Humans

This is a "connection" page, showing publications Jesse Bloom has written about Humans.
Connection Strength

0.174
  1. Recovery of Deleted Deep Sequencing Data Sheds More Light on the Early Wuhan SARS-CoV-2 Epidemic. Mol Biol Evol. 2021 12 09; 38(12):5211-5224.
    View in: PubMed
    Score: 0.008
  2. Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies. Nat Commun. 2021 07 07; 12(1):4196.
    View in: PubMed
    Score: 0.008
  3. Antibodies elicited by mRNA-1273 vaccination bind more broadly to the receptor binding domain than do those from SARS-CoV-2 infection. Sci Transl Med. 2021 06 30; 13(600).
    View in: PubMed
    Score: 0.008
  4. Investigate the origins of COVID-19. Science. 2021 05 14; 372(6543):694.
    View in: PubMed
    Score: 0.008
  5. A human coronavirus evolves antigenically to escape antibody immunity. PLoS Pathog. 2021 04; 17(4):e1009453.
    View in: PubMed
    Score: 0.008
  6. Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies. Cell Host Microbe. 2021 03 10; 29(3):463-476.e6.
    View in: PubMed
    Score: 0.007
  7. Dynamics of Neutralizing Antibody Titers in the Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection. J Infect Dis. 2021 02 03; 223(2):197-205.
    View in: PubMed
    Score: 0.007
  8. Prospective mapping of viral mutations that escape antibodies used to treat COVID-19. Science. 2021 02 19; 371(6531):850-854.
    View in: PubMed
    Score: 0.007
  9. Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition. Cell Host Microbe. 2021 01 13; 29(1):44-57.e9.
    View in: PubMed
    Score: 0.007
  10. Attenuated Influenza Virions Expressing the SARS-CoV-2 Receptor-Binding Domain Induce Neutralizing Antibodies in Mice. Viruses. 2020 09 05; 12(9).
    View in: PubMed
    Score: 0.007
  11. Serological identification of SARS-CoV-2 infections among children visiting a hospital during the initial Seattle outbreak. Nat Commun. 2020 09 01; 11(1):4378.
    View in: PubMed
    Score: 0.007
  12. Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding. Cell. 2020 09 03; 182(5):1295-1310.e20.
    View in: PubMed
    Score: 0.007
  13. Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays. Viruses. 2020 05 06; 12(5).
    View in: PubMed
    Score: 0.007
  14. Single-Cell Virus Sequencing of Influenza Infections That Trigger Innate Immunity. J Virol. 2019 07 15; 93(14).
    View in: PubMed
    Score: 0.007
  15. Massively Parallel Profiling of HIV-1 Resistance to the Fusion Inhibitor Enfuvirtide. Viruses. 2019 05 15; 11(5).
    View in: PubMed
    Score: 0.007
  16. Deep mutational scanning of hemagglutinin helps predict evolutionary fates of human H3N2 influenza variants. Proc Natl Acad Sci U S A. 2018 08 28; 115(35):E8276-E8285.
    View in: PubMed
    Score: 0.006
  17. Complete functional mapping of infection- and vaccine-elicited antibodies against the fusion peptide of HIV. PLoS Pathog. 2018 07; 14(7):e1007159.
    View in: PubMed
    Score: 0.006
  18. How single mutations affect viral escape from broad and narrow antibodies to H1 influenza hemagglutinin. Nat Commun. 2018 04 11; 9(1):1386.
    View in: PubMed
    Score: 0.006
  19. Within-Host Evolution of Human Influenza Virus. Trends Microbiol. 2018 09; 26(9):781-793.
    View in: PubMed
    Score: 0.006
  20. Extreme heterogeneity of influenza virus infection in single cells. Elife. 2018 02 16; 7.
    View in: PubMed
    Score: 0.006
  21. Parallel evolution of influenza across multiple spatiotemporal scales. Elife. 2017 06 27; 6.
    View in: PubMed
    Score: 0.006
  22. Comprehensive Mapping of HIV-1 Escape from a Broadly Neutralizing Antibody. Cell Host Microbe. 2017 Jun 14; 21(6):777-787.e4.
    View in: PubMed
    Score: 0.006
  23. Deep mutational scanning identifies sites in influenza nucleoprotein that affect viral inhibition by MxA. PLoS Pathog. 2017 03; 13(3):e1006288.
    View in: PubMed
    Score: 0.006
  24. Broad sarbecovirus neutralization by a human monoclonal antibody. Nature. 2021 09; 597(7874):103-108.
    View in: PubMed
    Score: 0.002
  25. SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape. Nature. 2021 09; 597(7874):97-102.
    View in: PubMed
    Score: 0.002
  26. Stabilization of the SARS-CoV-2 Spike Receptor-Binding Domain Using Deep Mutational Scanning and Structure-Based Design. Front Immunol. 2021; 12:710263.
    View in: PubMed
    Score: 0.002
  27. Spread of a SARS-CoV-2 variant through Europe in the summer of 2020. Nature. 2021 07; 595(7869):707-712.
    View in: PubMed
    Score: 0.002
  28. Neutralizing Antibodies Correlate with Protection from SARS-CoV-2 in Humans during a Fishery Vessel Outbreak with a High Attack Rate. J Clin Microbiol. 2020 10 21; 58(11).
    View in: PubMed
    Score: 0.002
  29. Destabilized adaptive influenza variants critical for innate immune system escape are potentiated by host chaperones. PLoS Biol. 2018 09; 16(9):e3000008.
    View in: PubMed
    Score: 0.002
  30. Sera from Individuals with Narrowly Focused Influenza Virus Antibodies Rapidly Select Viral Escape Mutations In Ovo. J Virol. 2018 10 01; 92(19).
    View in: PubMed
    Score: 0.002
  31. Enhanced ER proteostasis and temperature differentially impact the mutational tolerance of influenza hemagglutinin. Elife. 2018 09 06; 7.
    View in: PubMed
    Score: 0.002
  32. A framework for exhaustively mapping functional missense variants. Mol Syst Biol. 2017 12 21; 13(12):957.
    View in: PubMed
    Score: 0.001
  33. The global spread of drug-resistant influenza. J R Soc Interface. 2012 Apr 07; 9(69):648-56.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.